Gender-related association between the -93T→G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemia

被引:25
作者
Hoffer, MJV
Bredie, SJH
Snieder, H
Reymer, PWA
Demacker, PNM
Havekes, LM
Boomsma, DI
Stalenhoef, AFH
Frants, RR
Kastelein, JJP
机构
[1] Leiden Univ, Med Ctr, Dept Human Genet, MGC, NL-2300 RA Leiden, Netherlands
[2] Univ Nijmegen Hosp, Dept Med, Div Gen Internal Med, NL-6500 HB Nijmegen, Netherlands
[3] Free Univ Amsterdam, Dept Psychophysiol, Amsterdam, Netherlands
[4] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands
[5] TNO, Gaubius Lab, PG, Leiden, Netherlands
关键词
familial combined hyperlipidemia; lipoprotein lipase; family study; mutation analysis; genetic predisposition;
D O I
10.1016/S0021-9150(98)00007-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Familial combined hyperlipidemia (FCHL) is a frequent cause of premature coronary artery disease. Affected family members are characterized by different combinations of elevated cholesterol and/or triglyceride levels. A reduction in lipoprotein lipase (LPL) activity has been observed in a subgroup of FCHL patients. Recently, we have demonstrated an increased frequency of mutations in the LPL gene in Dutch FCHL patients compared to normolipidemic controls. In the present study, we have applied a pedigree-based maximum likelihood method to study the effect of LPL mutations on the phenotypic expression of FCHL in families. In 40 FCHL probandi, three different previously reported mutations in the LPL gene were identified resulting in amino acid changes, D9N, N291S, and S447X. The D9N mutation in exon 2 appeared to be in strong linkage disequilibrium with a T --> G substitution at position -93 in the promoter region of the LPL gene. We present data that the -93T --> G/D9N haplotype is associated with significantly higher levels of LDL and VLDL cholesterol, and VLDL triglycerides. Interestingly, the effect was only observed in male carriers. In line with our previous observations, these results further sustain that the LPL gene is a susceptibility gene for dyslipidemia which explains part of the variability in the phenotype observed among FCHL family members. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:91 / 99
页数:9
相关论文
共 50 条
[1]  
Assmann G, 1993, LIPID METABOLISM DIS, P19
[2]   INHERITANCE OF LOW-DENSITY-LIPOPROTEIN SUBCLASS PATTERNS IN FAMILIAL COMBINED HYPERLIPIDEMIA [J].
AUSTIN, MA ;
BRUNZELL, JD ;
FITCH, WL ;
KRAUSS, RM .
ARTERIOSCLEROSIS, 1990, 10 (04) :520-530
[3]   FAMILIAL COMBINED HYPERLIPIDEMIA AND ABNORMAL LIPOPROTEIN-LIPASE [J].
BABIRAK, SP ;
BROWN, BG ;
BRUNZELL, JD .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (10) :1176-1183
[4]   DETECTION AND CHARACTERIZATION OF THE HETEROZYGOTE STATE FOR LIPOPROTEIN-LIPASE DEFICIENCY [J].
BABIRAK, SP ;
IVERIUS, PH ;
FUJIMOTO, WY ;
BRUNZELL, JD .
ARTERIOSCLEROSIS, 1989, 9 (03) :326-334
[5]   COMPARISON OF GEMFIBROZIL VERSUS SIMVASTATIN IN FAMILIAL COMBINED HYPERLIPIDEMIA AND EFFECTS ON APOLIPOPROTEIN-B-CONTAINING LIPOPROTEINS, LOW-DENSITY-LIPOPROTEIN SUBFRACTION PROFILE, AND LOW-DENSITY-LIPOPROTEIN OXIDIZABILITY [J].
BREDIE, SJH ;
DEBRUIN, TWA ;
DEMACKER, PNM ;
KASTELEIN, JJP ;
STALENHOEF, AFH .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (05) :348-353
[6]  
BRUNZELL JD, 1994, METABOLIC BASIS INHE, P59
[7]   DNA POLYMORPHISMS AT THE LIPOPROTEIN-LIPASE GENE - ASSOCIATIONS IN NORMAL AND HYPERTRIGLYCERIDEMIC SUBJECTS [J].
CHAMBERLAIN, JC ;
THORN, JA ;
OKA, K ;
GALTON, DJ ;
STOCKS, J .
ATHEROSCLEROSIS, 1989, 79 (01) :85-91
[8]   COMPLEX SEGREGATION ANALYSIS PROVIDES EVIDENCE FOR A MAJOR GENE ACTING ON SERUM TRIGLYCERIDE LEVELS IN 55 BRITISH FAMILIES WITH FAMILIAL COMBINED HYPERLIPIDEMIA [J].
CULLEN, P ;
FARREN, B ;
SCOTT, J ;
FARRALL, M .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (08) :1233-1249
[9]   Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia [J].
DeBruin, TWA ;
Mailly, F ;
VanBarlingen, HHJJ ;
Fisher, R ;
Cabezas, MC ;
Talmud, P ;
DallingaThie, GM ;
Humphries, SE .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1996, 26 (08) :631-639
[10]   CORRECTION [J].
DEEB, SS .
BIOCHEMISTRY, 1989, 28 (16) :6786-6786